RSS

drug–drug interaction risk calculator (DDIRC)

Elsevier, an information analytics business, is working together with a set of evaluation partners including Boehringer Ingelheim, Eli Lilly and Company, Pierre Fabre, Sanofi, Servier, and others to develop a new DDIRC. Read more

News